Mary S. El-Masry

Hematology
9090 Wilshire Blvd Ste 300
Beverly Hills, CA 90211

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.

Journal: NPJ breast cancer
Published: August 11, 2022
Showing 1-1 of 1

Last Updated: 09/26/2026